Pharmacokinetics and milk penetration of orbifloxacin after intravenous and intramuscular injections to dromedary lactating camels (Camelus dromedaries)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 3, 2008, Pages 276-280

  Goudah, A ^a   Abo El Sooud, K ^a  

^a Cairo University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ORBIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CAMEL; CAMELUS DROMEDARIES; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG PENETRATION; FEMALE; FOOD CONTAMINATION; FOOD SAFETY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LACTATION; MILK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PKA; PRIORITY JOURNAL; RANK SUM TEST;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAMELS; CIPROFLOXACIN; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LACTATION; MILK;

CAMELIDAE; CAMELUS DROMEDARIUS;

EID: 43549113550     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00954.x     Document Type: Article

References (24)

1. Abd El-Aty, A.M. Goudah, A. (2002) Some pharmacokinetic parameters of pefloxacin in lactating goats. Veterinary Research Communications, 26, 553 561.
2. Abd El-Aty, A.M., Goudah, A., Shah, S.S., Shin, H.C., Shimoda, M. Shim, J.H. (2007) Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 30, 586 591.
3. Aliabadi, F.S., Ali, B.H., Landoni, M.F. Lees, P. (2003) Pharmacokinetics and PK-PD modeling of danofloxacin in camel serum and tissue cage fluids. Veterinary Journal, 165, 104 118.
4. Bennett, J.V., Brodie, J.L., Benner, E.J. Kirby, W.M. (1966) Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiology, 14, 170 177.
5. Carceles, C.M., Villamayor, L., Escudero, E., Marin, P. Fernandez-Varon, E. (2007) Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. The Veterinary Journal, 173, 452 455.
6. Craig, A.W. Suh, B. (1991) Protein binding and the antibacterial effects. Method for the determination of protein binding. In Antibiotics in laboratory Medicine, 3rd edn. Ed Lorian, V., pp. 367 402. Williams & Wilkins, Baltimore, Maryland, USA.
7. Davis, J.L., Papich, M.G. Weingarten, A. (2006) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191 197.
8. Fernandez-Varon, E., Villamayor, L., Escudero, E., Espuny, A. Carceles, C.M. (2006) Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. Veterinary Journal, 172, 302 307.
9. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn, pp. 409 424. Marcel Dekker, New York.
10. Haines, G.R., Brown, M.P., Gronwall, R.R., Merritt, K.A. Baltzley, L.K. (2001) Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Canadian Journal of Veterinary Research, 65, 181 187.
11. Hegazy, A.A., El-Dughaym, A., Alaknah, M., Housawi, F.M.T. Hatem, M.E. (2004) Studies on mastitis in female camel with special reference to brucellosis. Journal of Camel Science, 1, 96 102.
12. Heinen, E. (2002) Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25, 1 5.
13. Ihrke, P.J., Papich, M.G. Demanuelle, T.C. (1999) The use of fluoroquinolones in veterinary dermatology. Veterinary Dermatology, 10, 193 204.
14. Jonker, J.W., Merino, G. Musters, S. (2005) The breast cancer resistance protein BCRP(ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine, 11, 127 129.
15. Laraje, R., Talmi, A., Bounaga, R., Bengoumi, M., El Hraiki, A. Laurentie, M. (2006) Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedaries). Journal of Veterinary Pharmacology and Therapeutics, 29, 229 231.
16. Lode, H., Borner, K. Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Diseases, 27, 33 39.
17. Marín, P., Escudero, E., Fernández-Varón, E. Cárceles, C.M. (2007) Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats. Journal of Dairy Science, 90, 4219 4225.
18. McKellar, Q., Gibson, I., Monteiro, A. Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988 1992.
19. Nakamura, S. (1995) Veterinary use of the new quinolones in Japan. Drugs, 49, 152 158.
20. Petracca, K., Riond, J.L., Graser, T. Wanner, M. (1993) Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Zentralblatt fur Veterinarmedizin, Reihe, A., 40, 73 79.
21. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G. Alvarez, A.I. (2006) Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics, 29, 279 287.
22. Wolfson, J.S. Hooper, D.C. (1989) Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews, 2, 378 424.
23. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Statistical moment in pharmacokinetics. Journal of Pharmacokinetic and Biopharmaceutics, 6, 547 558.
24. Ziv, G., Kurtz, B., Risenberg, R. Glickman, A. (1995) Serum and milk concentrations of apramycin in lactating cows, ewes and goats. Journal of Veterinary Pharmacology and Therapeutics, 18, 346 351.